Drug Stock: Taro Pharmaceutical One Of America’s Opportunities

Drugmaker Taro Pharmaceutical was one of the rare exceptions of a stock that advanced over a period of 40 weeks while the S&P 500 was descending into a bear market. The reason: Its generic drugs were a way for consumers to save money during a recession. Plus, Taro’s earnings were growing. Taro was an Israeli company that manufactured and sold…